Vor Bio to Participate in the Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will host in-person 1x1 investor meetings at the 2023 Wedbush PacGrow Healthcare Conference.

Wedbush PacGrow Healthcare Conference
1x1 Investor Meetings: August 8-9, 2023
Location: Lotte Palace Hotel, New York, NY

About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com


Primary Logo

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.41
+1.19 (0.51%)
AAPL  279.71
+0.86 (0.31%)
AMD  219.12
+1.59 (0.73%)
BAC  53.56
-0.09 (-0.17%)
GOOG  318.15
-1.97 (-0.62%)
META  643.73
-4.22 (-0.65%)
MSFT  489.11
-2.90 (-0.59%)
NVDA  179.99
+2.99 (1.69%)
ORCL  201.81
-0.14 (-0.07%)
TSLA  430.42
+0.25 (0.06%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.